| Category: Equity: Sectoral-Pharma and Healthcare |
| Launch Date: 05-11-2018 |
| Asset Class: Equity |
| Benchmark: BSE Healthcare TRI |
| TER: 1.93% As on (29-09-2025) |
| Status: Open Ended Schemes |
| Minimum Investment: 100.0 |
| Minimum Topup: 100.0 |
| Total Assets: 3,074.18 Cr As on 30-09-2025(Source:AMFI) |
| Turn over: 6% | Exit Load: 0.50% - Holding period from the date of allotment <= 1 month, Nil - Holding period from the date of allotment > 1 month (as a % of Applicable NAV) |
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. There is no assurance that the investment objective of the Scheme will be achieved
| Standard Deviation | 14.71 |
| Sharpe Ratio | 1.06 |
| Alpha | 4.64 |
| Beta | 0.79 |
| Yield to Maturity | - |
| Average Maturity | - |
Minimum investment in equity & equity related instruments of a particular sector/ particular theme - 80% of total assets.
Small Cap
47.61%
Others
13.33%
Large Cap
23.46%
Mid Cap
15.6%